Featured Product
This Week in Quality Digest Live
FDA Compliance Features
Stephanie Ojeda
How addressing customer concerns benefits the entire quality process
Michael King
Augmenting and empowering life-science professionals
Meg Sinclair
100% real, 100% anonymized, 100% scary
Alonso Diaz
Consulting the FDA’s Case for Quality program
Four data layers that matter

More Features

FDA Compliance News
Recognized among early adopters as a leading innovation for the life sciences industry
Streamlines annual regulatory review for life sciences
Facilitates quick sanitary compliance and production changeover
Creates one of the most comprehensive regulatory SaaS platforms for the industry
Company’s first funding round will be used to accelerate product development for its QMS and MES SaaS offerings
Showcasing tech, solutions, and services at Gulfood Manufacturing 2022
Easy, reliable leak testing with methylene blue
Now is not the time to skip critical factory audits and supply chain assessments
Google Docs collaboration, more efficient management of quality deviations

More News

Quality Digest

FDA Compliance

ArisGlobal Signs Agreement to Acquire Amplexor Life Sciences

Creates one of the most comprehensive regulatory SaaS platforms for the industry

Published: Tuesday, March 14, 2023 - 11:00

(ArisGlobal: Miami; Amplexor Life Sciences: Novo Mesto, Slovenia) -- ArisGlobal, a leading provider of life sciences software designed to automate core drug development functions with its end-to-end technology platform LifeSphere, has acquired Amplexor Life Sciences (LS), a global provider of regulatory, quality, and safety software solutions, serving and trusted by pharmaceutical, biotechnology, and medical device companies.  

The integration of the regulatory product lines will bring a distinct set of benefits to customers. LifeSphere users can now gain access to enhanced publishing and labeling capabilities, in addition to a robust quality management system (QMS) from Amplexor LS.  Amplexor LS’s regulatory customers can now connect to even wider functionality through ArisGlobal’s market-leading LifeSphere platform, including access to state-of-the-art safety, medical affairs, and clinical solutions.  

This combined product ecosystem provides a new opportunity for life sciences companies, bringing together best-in-breed solutions to form a cohesive solution serving customers’ regulatory needs. It also represents many years of industry expertise, software innovation, and customer excellence from ArisGlobal and Amplexor Life Sciences. This move accelerates both companies’ road maps and increases efficiency in bringing new therapies to the market.  

 “For many years, ArisGlobal has been focused on building a regulatory platform that provides a market-leading, comprehensive set of products, and streamlines processes supporting collaboration across distributed teams while adhering to extensive and evolving global regulatory requirements,” says Mike Gordon, chief executive officer at ArisGlobal. “By combining our core functionalities, we are elevating our end-to-end regulatory capabilities to enhance our customers’ journey.”

“Amplexor Life Sciences has always sought to provide their customers with operational excellence in global compliance, and this new chapter of our products within the LifeSphere regulatory platform will continue to do that,” says Elvis Paćelat, executive vice president at Amplexor LS. “We are excited to join forces with ArisGlobal, which has been an innovator in the life sciences space for several decades, to provide the market with a full scope of products designed to make regulatory processes a connected, cloud-based, and compliant experience.”    

“The vision and objectives of ArisGlobal and Amplexor LS are aligned,” says Jim Hilferty, assistant vice president and head of regulatory products at ArisGlobal. “We’re confident that bringing our organizations together will serve as a catalyst for innovation to benefit life sciences, and allow us to deliver the most intelligent, connected, and comprehensive platform available to the regulatory community.”

Both companies have been supporting R&D processes through technology for decades, with offices throughout Europe, the United States, India, and the Asian-Pacifiic region.   

The integration is subject to customary government approvals that are expected to be completed during the next 60 days. Further information will be made available on the combined solution. 

For more information, visit arisglobal.com and amplexorlifesciences.com.


About The Author

Quality Digest’s picture

Quality Digest

For 40 years Quality Digest has been the go-to source for all things quality. Our newsletter, Quality Digest, shares expert commentary and relevant industry resources to assist our readers in their quest for continuous improvement. Our website includes every column and article from the newsletter since May 2009 as well as back issues of Quality Digest magazine to August 1995. We are committed to promoting a view wherein quality is not a niche, but an integral part of every phase of manufacturing and services.